|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 2003; 41:56-61 © 2003 by the American College of Cardiology Foundation |
* Stanford Center for Research in Disease Prevention, Stanford University, Palo Alto, California, USA
Yale University School of Epidemiology and Public Health, New Haven, Connecticut, USA
Manuscript received March 14, 2002; revised manuscript received August 21, 2002, accepted September 26, 2002.
* Reprint requests and correspondence: Dr. Randall S. Stafford, Stanford Center for Research in Disease Prevention, 1000 Welch Road, Palo Alto, California 94304, USA.
rstafford{at}stanford.edu
OBJECTIVES: To evaluate recent trends, we examined longitudinal national data on the outpatient use of warfarin in atrial fibrillation (AF), beta-blockers and aspirin in coronary artery disease (CAD), and angiotensin-converting enzyme inhibitors (ACEIs) in congestive heart failure (CHF).
BACKGROUND: Previous studies indicate that specific cardiac medications are underutilized.
METHODS: We used the National Disease and Therapeutic Index (NDTI) (produced by IMS HEALTH, Plymouth Meeting, Pennsylvania) for 1990 to 2002, and the National Ambulatory Medical Care Surveys (NAMCS) for 1990 to 2000 to follow nationally representative samples of outpatient visits. For visits by patients with AF (total n = 14,634 visits), CAD (n = 35,295), and CHF (n = 33,008), we examined trends in the proportion of visits with the selected medications reported.
RESULTS: Warfarin use in AF increased from 12% in 1990, to 41% in 1995, to 58% in 2001 in NDTI; a similar moderation of recent increase was seen in NAMCS. For CAD in NDTI, beta-blocker use increased slowly from 19% in 1990, to 20% in 1995, then to 40% in 2001; NAMCS showed this same pattern. Aspirin use in CAD in NDTI increased from 18% in 1990, to 19% in 1995, to 38% in 2001; NAMCS, however, showed lower use rates. For NDTI, ACEI use in CHF increased from 24% in 1990 to 36% in 1996, but increased to only 39% by 2001, a general pattern also seen in NAMCS.
CONCLUSIONS: Both national datasets demonstrate continuing underutilization of these cardiac medications of proven benefit. Although use is increasing, it remains lower than expected, and some increases noted in earlier years have slowed. Substantial public health benefits would result from further adoption of these effective therapies.
| ||||||||||||||||
This article has been cited by other articles:
|
|
 |
|
  N. K. Choudhry, A. R. Patrick, E. M. Antman, J. Avorn, and W. H. Shrank Cost-Effectiveness of Providing Full Drug Coverage to Increase Medication Adherence in Post-Myocardial Infarction Medicare Beneficiaries Circulation, March 11, 2008; 117(10): 1261 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Esteban, N. D. Ferguson, M. O. Meade, F. Frutos-Vivar, C. Apezteguia, L. Brochard, K. Raymondos, N. Nin, J. Hurtado, V. Tomicic, et al. Evolution of Mechanical Ventilation in Response to Clinical Research Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 170 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Nutescu ASHP Therapeutic Position Statement on Antithrombotic Therapy in Chronic Atrial Fibrillation Am. J. Health Syst. Pharm., November 1, 2007; 64(21): 2281 - 2291. [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Goldberg, F. A. Spencer, P. G. Steg, M. Flather, G. Montalescot, E. P. Gurfinkel, B. M. Kennelly, S. G. Goodman, R. Dedrick, J. M. Gore, et al. Increasing Use of Single and Combination Medical Therapy in Patients Hospitalized for Acute Myocardial Infarction in the 21st Century: A Multinational Perspective Arch Intern Med, September 10, 2007; 167(16): 1766 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. R. Wang Lack of Effect of Guideline Changes on Hypertension Control for Patients With Diabetes in the U.S., 1995-2005 Diabetes Care, January 1, 2007; 30(1): 49 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Zerumsky and B. F. McBride Ranolazine in the management of chronic stable angina Am. J. Health Syst. Pharm., December 1, 2006; 63(23): 2331 - 2338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C M. White Ensuring that Patients Receive Full Cardiac Pharmacotherapy Services: A Pharmacist's Call to Arms Ann. Pharmacother., December 1, 2006; 40(12): 2248 - 2250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Aberegg, H. Arkes, and P. B. Terry Failure to Adopt Beneficial Therapies Caused by Bias in Medical Evidence Evaluation. Med Decis Making, November 1, 2006; 26(6): 575 - 582. [Abstract] [PDF]
|
|
|
|
|
|
G. S. Hillis, K. J. Zehr, A. W. Williams, H. V. Schaff, T. A. Orzulak, R. C. Daly, C. J. Mullany, R. J. Rodeheffer, and J. K. Oh Outcome of Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting: Renal Function and Mortality After 3.8 Years Circulation, July 4, 2006; 114(1_suppl): I-414 - I-419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Radley, S. N. Finkelstein, and R. S. Stafford Off-label Prescribing Among Office-Based Physicians. Arch Intern Med, May 8, 2006; 166(9): 1021 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Clark Commentary by Clark West J Nurs Res, March 1, 2006; 28(2): 210 - 213. [PDF]
|
|
|
|
|
|
Y. R. Wang, G. C. Alexander, and D. O. Meltzer Lack of Effect of Guideline Changes on LDL Cholesterol Reporting and Control for Diabetes Visits in the U.S., 1995-2004 Diabetes Care, December 1, 2005; 28(12): 2942 - 2944. [Full Text] [PDF]
|
|
|
|
|
|
J. C. Fang Angiotensin-Converting Enzyme Inhibitors or {beta}-Blockers in Heart Failure: Does It Matter Who Goes First? Circulation, October 18, 2005; 112(16): 2380 - 2382. [Full Text] [PDF]
|
|
|
|
|
|
V. F. Tapson, T. M. Hyers, A. L. Waldo, D. J. Ballard, R. C. Becker, J. A. Caprini, R. Khetan, A. K. Wittkowsky, K. J. Colgan, A. C. Shillington, et al. Antithrombotic Therapy Practices in US Hospitals in an Era of Practice Guidelines Arch Intern Med, July 11, 2005; 165(13): 1458 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Sequist, T. K. Gandhi, A. S. Karson, J. M. Fiskio, D. Bugbee, M. Sperling, E. F. Cook, E. J. Orav, D. G. Fairchild, and D. W. Bates A Randomized Trial of Electronic Clinical Reminders to Improve Quality of Care for Diabetes and Coronary Artery Disease J. Am. Med. Inform. Assoc., July 1, 2005; 12(4): 431 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lam and C. M. Ruby Impact of an interdisciplinary team on drug therapy outcomes in a geriatric clinic Am. J. Health Syst. Pharm., March 15, 2005; 62(6): 626 - 629. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Roman-Sanchez, P. Conthe, J. Garcia-Alegria, J. Forteza-Rey, M. Montero, C. Montoto, and for the Heart Failure Working Group of the Spanish Factors influencing medical treatment of heart failure patients in Spanish internal medicine departments: a national survey QJM, February 1, 2005; 98(2): 127 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Ezekowitz, C. van Walraven, F. A. McAlister, P. W. Armstrong, and P. Kaul Impact of specialist follow-up in outpatients with congestive heart failure Can. Med. Assoc. J., January 18, 2005; 172(2): 189 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. F. McBride and C. M. White Critical Differences Among Beta-Adrenoreceptor Antagonists in Myocardial Failure: Debating the MERIT of COMET J. Clin. Pharmacol., January 1, 2005; 45(1): 6 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Galbreath, R. A. Krasuski, B. Smith, K. C. Stajduhar, M. D. Kwan, R. Ellis, and G. L. Freeman Long-Term Healthcare and Cost Outcomes of Disease Management in a Large, Randomized, Community-Based Population With Heart Failure Circulation, December 7, 2004; 110(23): 3518 - 3526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J Khoury, R. Millikan, J. Little, and M. Gwinn The emergence of epidemiology in the genomics age Int. J. Epidemiol., October 1, 2004; 33(5): 936 - 944. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Hlatky Underuse of Evidence-Based Therapies Circulation, August 10, 2004; 110(6): 644 - 645. [Full Text] [PDF]
|
|
|
|
|
|
T. J. Gluckman, B. Baranowski, M. D. Ashen, C. A. Henrikson, M. McAllister, J. B. Braunstein, and R. S. Blumenthal A Practical and Evidence-Based Approach to Cardiovascular Disease Risk Reduction Arch Intern Med, July 26, 2004; 164(14): 1490 - 1500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Eidelman, D. Hollar, P. R. Hebert, G. A. Lamas, and C. H. Hennekens Randomized Trials of Vitamin E in the Treatment and Prevention of Cardiovascular Disease Arch Intern Med, July 26, 2004; 164(14): 1552 - 1556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Majumdar, F. A. McAlister, and C. D. Furberg From knowledge to practice in chronic cardiovascular disease: a long and winding road J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1738 - 1742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bode Recent trials in atrial fibrillation: lessons learned beyond rate and rhythm Eur. Heart J. Suppl., April 1, 2004; 6(suppl_B): B15 - B19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. D. White and J. T. Willerson We Must Use the Knowledge That We Have to Treat Patients With Acute Coronary Syndromes Circulation, February 17, 2004; 109(6): 698 - 700. [Full Text] [PDF]
|
|
|
|
|
|
D. Mukherjee, J. Fang, S. Chetcuti, M. Moscucci, E. Kline-Rogers, and K. A. Eagle Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary Syndromes Circulation, February 17, 2004; 109(6): 745 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Leclercq and J. M. Hare Ventricular Resynchronization: Current State of the Art Circulation, January 27, 2004; 109(3): 296 - 299. [Full Text] [PDF]
|
|
|
|
|
|
M. C. Fang, R. S. Stafford, J. N. Ruskin, and D. E. Singer National Trends in Antiarrhythmic and Antithrombotic Medication Use in Atrial Fibrillation Arch Intern Med, January 12, 2004; 164(1): 55 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Montori, S. C. Bryant, A. M. O'Connor, N. W. Jorgensen, E. E. Walsh, and S. A. Smith Decisional Attributes of Patients With Diabetes: The aspirin choice Diabetes Care, October 1, 2003; 26(10): 2804 - 2809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lenfant Clinical Research to Clinical Practice -- Lost in Translation? N. Engl. J. Med., August 28, 2003; 349(9): 868 - 874. [Full Text] [PDF]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
